Definitions
from The American Heritage® Dictionary of the English Language, 5th Edition.
- noun A family of glycoproteins that are produced by fibroblasts, have antiviral properties, and are used in the treatment of multiple sclerosis.
from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.
- noun a form of interferon that is produced by fibroblasts and have antiviral effects; used in the treatment of multiple sclerosis
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word beta-interferon.
Examples
-
Gilenya has been available in the European Union since March 2011 for treating relapsing-remitting MS, the most common type of the disease, in patients who have failed to respond to a beta-interferon or whose condition is severe and worsening rapidly.
EU Regulator Reviews Novartis MS Pill Sten Stovall 2012
-
Manufacturers of various forms of beta-interferon include Biogen Idec Inc.,
New Insight Into Multiple-Sclerosis Treatment Thomas M. Burton 2010
-
The research, published online Sunday in Nature Medicine, could have repercussions in the $4 billion beta-interferon industry.
New Insight Into Multiple-Sclerosis Treatment Thomas M. Burton 2010
-
The researchers, led by Lawrence Steinman and Robert C. Axtell of Stanford's neurology department, concluded that a simple blood test could indicate which patients are most likely to benefit from beta-interferon, which minimizes the relapses suffered by some but not all MS patients.
New Insight Into Multiple-Sclerosis Treatment Thomas M. Burton 2010
-
Manufacturers of various forms of beta-interferon include Biogen Idec Inc.,
Multiple-Sclerosis Study Could Help Patients Thomas M. Burton 2010
-
Differentiating between responders and nonresponders to beta-interferon could help thousands of people skip the drug and avoid the flu-like symptoms that accompany it, while assuring others that they are likely to benefit, doctors said.
New Insight Into Multiple-Sclerosis Treatment Thomas M. Burton 2010
-
One pathway corresponded to people who respond to beta-interferon, the other to people who don't.
New Insight Into Multiple-Sclerosis Treatment Thomas M. Burton 2010
-
The research, published online Sunday in Nature Medicine, could have repercussions in the $4 billion beta-interferon industry.
Multiple-Sclerosis Study Could Help Patients Thomas M. Burton 2010
-
The researchers, led by Lawrence Steinman and Robert C. Axtell of Stanford's neurology department, concluded that a simple blood test could indicate which patients were most likely to benefit from beta-interferon, which minimizes the relapses suffered by some MS patients.
Multiple-Sclerosis Study Could Help Patients Thomas M. Burton 2010
-
Differentiating between responders and nonresponders to beta-interferon could help thousands of people skip the drug and avoid the flu-like symptoms that accompany it, while assuring others that they are likely to benefit, doctors said.
Multiple-Sclerosis Study Could Help Patients Thomas M. Burton 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.